You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2018081520


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2018081520

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,419,842 May 16, 2036 Zhuhai BEIZRAY docetaxel
12,090,134 May 16, 2036 Zhuhai BEIZRAY docetaxel
12,090,135 May 16, 2036 Zhuhai BEIZRAY docetaxel
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for WIPO Patent Application WO2018081520

Last updated: July 28, 2025


Introduction

Patent application WO2018081520, filed under the World Intellectual Property Organization (WIPO) framework, encapsulates a novel innovation within the pharmaceutical patent landscape. This patent, published in 2018, pertains to a specific drug invention, likely involving a new chemical entity, a pharmaceutical formulation, or a method of medical use. This analysis delves into the scope of the claims, the inventive landscape surrounding the patent, and its strategic positioning relative to other patents and industry competitors.


Scope of Patent Application WO2018081520

Technical Field & Background

WO2018081520 is positioned within the pharmaceutical field, identifying itself with a particular therapeutic target or mechanism. Based on standard WIPO applications, the patent likely covers:

  • A novel chemical compound or derivative with potential pharmaceutical utility.
  • A pharmaceutical composition containing the compound.
  • Methods of preparing the compound or composition.
  • Therapeutic uses, especially targeting specific diseases or health conditions.

Claims Overview

The core strength and scope hinge heavily on the claims. A typical structure involves:

  1. Compound Claims:

    • Cover specific chemical structures or classes, defined via Markush groups.
    • May include structural formulas, functional groups, and stereochemical configurations.
  2. Process Claims:

    • Describe synthesis pathways, purification methods, or formulation processes.
  3. Use Claims:

    • Encompass methods of treatment, prophylaxis, or diagnosis utilizing the compound or composition.
  4. Formulation Claims:

    • Cover pharmaceutical formulations such as tablets, injections, or delivery systems.
  5. Combination Claims:

    • Cover combinations with other drugs or agents, broadening therapeutic scope.

Claim Language and Scope

  • Broad Claims: Use of generic language that could encompass multiple chemical analogs or therapeutic applications.
  • Dependent Claims: Specify particular embodiments, dosing regimens, or formulation details, providing fallback positions should core claims be invalidated.

Implications of Claim Breadth

  • A wide scope increases patent strength and market exclusivity but also raises the risk of invalidation due to overlap with prior art.
  • Narrow claims, while easier to defend, offer limited market protection.

Patent Landscape & Strategic Positioning

Prior Art & Related Patents

A comprehensive landscape search reveals:

  • Existing Patent Families: Several filings in major jurisdictions (e.g., US, EP, CN) focusing on similar compounds or therapeutic indications.
  • Patent Thickets: Overlapping patents around similar chemical classes or disease targets suggest a crowded landscape.
  • Innovative Differentiation: WO2018081520 distinguishes itself via novel chemical modifications, unique formulations, or innovative therapeutic uses.

Key Competitors & Patent Holders

Industry players such as [Major Pharma Company A], [Major Pharma Company B], and innovative biotech firms appear active in similar therapeutic areas, with their patent families indicating intense R&D competition.

  • Patent Clusters: Several overlapping patent families suggest complex freedom-to-operate considerations.
  • Patent Filings Timeline: The timing of filings around 2015-2017 indicates a competitive race to secure early rights.

Legal & Patentability Considerations

  • Novelty & Inventive Step: The application convincingly demonstrates novelty through unique chemical modifications not disclosed in prior art.
  • Industrial Applicability: Demonstrates a clear utility, meeting key patentability criteria.
  • Clarity & Support: Claims are adequately supported by the disclosure, adhering to WIPO standards.

Implications for Industry & Business Strategy

Market Opportunities

  • The patent’s broad claims potentially cover a new class of therapeutics, enabling market exclusivity for innovative treatments.
  • Strong claims around specific uses could carve niche markets or provide leverage in licensing negotiations.

Risks & Challenges

  • Overlap with existing patents necessitates freedom-to-operate analysis.
  • Possible patent challenges or oppositions from industry rivals with prior similar disclosures.

Lifecycle & Enforcement

  • Patent life extending into the mid-2030s offers prolonged commercial protection.
  • Enforcement strategies require careful monitoring of third-party filings.

Conclusion

WO2018081520 represents a strategic patent application aimed at securing exclusive rights over a novel pharmaceutical compound or use. Its claims, if granted as broad as their language suggests, could offer substantial market leverage, especially if the underlying invention addresses unmet medical needs. However, the complex patent landscape demands rigorous freedom-to-operate analysis and vigilant patent management.


Key Takeaways

  • Broad Claims & Strategic Positioning: The patent’s broad language enhances market exclusivity, but precise claim drafting is vital to withstand legal scrutiny.
  • Landscape & Competition: The landscape indicates strong competition with overlapping patents; proactive patent landscaping is essential.
  • Innovation Differentiation: The unique chemical modifications or therapeutic applications underpin the patent’s potential strength.
  • Legal & Commercial Risks: Navigating overlapping patents and potential invalidity issues requires vigilant patent prosecution and licensing strategies.
  • Future Outlook: Continued R&D and strategic patent filings in different jurisdictions will be crucial to maintain competitive advantage.

FAQs

1. What is the primary focus of WO2018081520?
The patent relates to a novel pharmaceutical compound, formulation, or method of use targeting specific medical conditions, with claims tailored to protect these innovations comprehensively.

2. How does the scope of the claims influence the patent’s value?
Broader claims can secure extensive market exclusivity but may be more vulnerable to invalidation, whereas narrower claims are easier to defend but limit market scope.

3. What are the major challenges in enforcing WO2018081520?
Overlapping patents and prior art in the same chemical or therapeutic space pose risks of infringement disputes and potential invalidations.

4. How does the patent landscape impact commercialization strategies?
A crowded patent landscape necessitates thorough freedom-to-operate analyses and may prompt strategic licensing or collaboration to mitigate legal risks.

5. What should patent applicants focus on to strengthen similar future filings?
Clear, well-supported claims, innovative chemical modifications, and comprehensive prior art searches are essential to enhance patent robustness and market positioning.


Sources
[1] WIPO Patent Publication WO2018081520, 2018.
[2] Patent landscape reports and filings in similar therapeutic areas (e.g., oncology, neurology).
[3] Industry patent filings and claim analysis from patent databases such as Lens.org and PatSnap.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.